PTEN and endometrial cancer: An endometrial cancer mouse model mimicking human EAC has been established using the progesterone receptor promoter driven Cre-recombinase (PR-Cre) to conditionally knockout Pten in the endometrium, resulting in rapid onset of EAC at 4 weeks of age, with infiltration into the myometrium by 8 weeks [3].